NCT05601583View on ClinicalTrials.gov

Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 19, 2023

Primary Completion Date

August 29, 2023

Study Completion Date

August 31, 2027

Conditions
Type 2 DiabetesMild Cognitive Impairment
Interventions
DEVICE

Continuous Glucose Monitor (CGM)

FDA-cleared FreeStyle Libre Glucose Monitoring System manufactured by Abbott. Integrated continuous glucose monitoring system that provides continuous glucose measurements every minute to provide glucose levels, trends and alerts.

Trial Locations (1)

10016

Bellevue Hospital, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER